Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alberto Maldonado Molina

Thoracic Surgery (Cardiothoracic Vascular Surgery) Ponce, PR Medical Doctor

NPI 1689641631 CMS profile 166760

2213 Ponce Byp, Ste 1002, Ponce, PR 00717

Open in the dashboard

General payments

$83,887

272 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alberto Maldonado Molina of Ponce, PR is reported in the CMS Open Payments database as having received $83,887 across 272 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $761 8
2024 General $2,918 36
2023 General $3,811 40
2022 General $1,629 31
2021 General $1,390 23
2020 General $11,217 25
2019 General $62,162 109

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alberto Maldonado Molina
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Alberto Maldonado Molina were reported at $761. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Alberto Maldonado Molina Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $62,162 $886 $178–$3,167 $163
2020 $11,217 $341 $108–$1,605 $114
2021 $1,390 $453 $125–$1,886 $132
2022 $1,629 $695 $180–$2,566 $149
2023 $3,811 $745 $205–$2,662 $160
2024 $2,918 $799 $214–$2,967 $164
2025 $761 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. LivaNova USA, Inc. $64,610 87 payments
  2. Intuitive Surgical, Inc. $8,861 16 payments
  3. Medtronic, Inc. $3,107 24 payments
  4. Medtronic Vascular, Inc. $1,650 21 payments
  5. Edwards Lifesciences Corporation $1,042 43 payments
  6. Silk Road Medical, Inc. $1,040 9 payments
  7. Abiomed $644 8 payments
  8. Corcym Inc $394 7 payments
  9. Bolton Medical Inc $349 3 payments
  10. Becton, Dickinson and Company $232 3 payments
  11. Other $1,959 51 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $50,800 15 payments
  2. Travel and Lodging $18,121 62 payments
  3. Food and Beverage $8,958 192 payments
  4. Education $6,000 2 payments
  5. Gift $9 1 payment
Products named General payments · program years 2019–2025
  1. Perceval $64,337 83 payments
  2. Da Vinci Surgical System $8,861 16 payments
  3. MICS Instruments $1,121 5 payments
  4. Memo4D $1,080 4 payments
  5. ENROUTE Transcarotid Stent $1,040 9 payments
  6. ENROUTE Transcarotid Neuroprotection System $1,040 9 payments
  7. ENHANCE Transcarotid Peripheral Access Kit $981 6 payments
  8. ENROUTE .014 Guidewire $981 6 payments
  9. MC3 NAUTILUS(TM) ECMO OXYGENATOR $858 5 payments
  10. CoreValve Evolut $785 10 payments
  11. Other $7,716 120 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

203

Median for Cardiac Surgery: 68

Drug cost

$2,210

Median for Cardiac Surgery: $445

Branded share of claims

27.6%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amiodarone Hcl Generic 23 $750
Clopidogrel Clopidogrel Bisulfate Brand 56 $522
Atorvastatin Calcium Generic 48 $364
Bumetanide Generic 15 $243
Metoprolol Tartrate Generic 32 $193
Furosemide Generic 29 $138

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Records

272 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Puerto Rico

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record